Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Ufp Technologies Q3 2026 Results: Net Income $20.6M, Up 25.8% YoY

UFP Technologies reported a 10.3% increase in net sales to $500.6 million for the nine months ended September 30, 2026, compared to the prior year. Net income grew to $59.0 million, or $7.56 per diluted share, driven by higher gross margins and operational efficiencies despite increased selling, general, and administrative expenses.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue172.4154.6
Gross profit50.842.7
Profit before tax26.121.1
Net income20.616.4
EPS (diluted, $ a share)$2.64$2.11

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Growth and margins
Net income, year on year+25.8%
Revenue, year on year+11.6%
Gross margin29.4%
Operating margin16.0%
Source

10-Q filed with the SEC, NASDAQ: UFPT. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Ufp Technologies Inc: key numbers

Share price
$298.54Close, Nov 16
Market cap
$2.31B
Shares outstanding
7.75MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Ufp Technologies Inc

All →
4:13 PM ET 8-K
Financial Results

Ufp Technologies Financial Results

UFP Technologies reported third quarter 2026 net income of $20.6 million on net sales of $172.4 million, representing 11.6% year-over-year growth. The results were driven by strong MedTech demand and organic sales growth of 11.1%, alongside scaling operations in the Dominican Republic.

Term
Q3 2026

“Our third quarter and year-to-date results reflect continued solid execution across the UFP platform and progress toward our long-term growth strategy. In the third quarter, sales grew 11.6%, including 11.1% organic growth, gross margins increased to 29.4%, and adjusted operating income grew 14.5%.”

Mitch Rock, President and Chief Executive Officer

“Looking ahead to 2027, we are optimistic about the strength and positioning of UFP. We have invested in additional capacity at DAS Medical to support double-digit growth and have continued to build and invest in the team.”

Mitch Rock, President and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.